Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet eoxPL Characterisation on and Off Aspirin
NCT05604118Completed
- Sponsor
- Cardiff University
- Start
- Aug 2016
- Primary completion
- Aug 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of aspirin in cardiovascular diseases (CVD) (2 arms), sponsored by Cardiff University. Primary endpoint: Platelet Enzymatically Oxidized Phospholipids differences in amounts at 4 months. Started Aug 2016; status: completed.
02
Drugs
aspirin
03
Conditions
cardiovascular diseases (CVD)
Beyond the preview
Go deeper on NCT05604118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05604118.